Applied Clinical Trials - Global Information & Resources to Develop, Execute and Manage Clinical Trials

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
See the latest Applied Clinical Trials digital edition!
See past issues of our digital edition here.
See our 2009 Buyers Guide Digital Edition.
Tell Us
Would you establish a REMs before the FDA required it?
Yes, if the drug presented risks
Yes, even if drug risks were marginal
No, it risks wasting money
Not yet, but will begin to
Yes, if the drug presented risks
0%
Yes, even if drug risks were marginal
100%
No, it risks wasting money
0%
Not yet, but will begin to
0%
View Results

ADVERTISEMENT

ADVERTISEMENT

Protecting Subjects: The IRBs Role Today
IRBs offer more on the procedures, ethics, compliance policies and the future needs necessary to protect humans in research... More
Click to download PDF
Sponsored By
Quorum Review IRB
Independent Review Consulting
Ethical Review Committee
IRB Services
Schulman Associates IRB
IntegReview
Goodwyn IRB
Aspire IRB
Trends in Subject Recruitment 2009
This insider's look into the subject recruitment industry describes the latest in recruitment and retention technologies and strategies... More
Click to download PDF
Sponsored By
Acurian
Clinical Performance Partners
D. Anderson & Company
MediciGlobal
MMG
Praxis
FindPharma
Featured Jobs

More Jobs

Previous StoryPlay / PauseNext Story
Phase Forward Signs Multi-Year Agreement with Quotient Clinical
November 5, 2009
ACM Global Central Laboratory Celebrates 10th Anniversary
November 5, 2009
Shire Extends Agreement with Medidata Solutions for Trial Planning Products
November 4, 2009
Cardiocore Thorough QT Performance Factors in FDAs Approval of Livalo
November 4, 2009
IntraLinks Announces Adobe-based Paperless Solution for Clinical Trial Process
November 4, 2009
Jill Wechsler–View from Washington
FDA Promotes Integrity and Compliance
View Past Articles>>
Peter O'Donnell– View from Brussels
Working Toward a Better Future
View Past Articles>>
Wayne R. Kubick –Technology Viewpoint
The Semantics of Health Care Interoperability
View Past Articles>>
Kenneth Getz –Clinical Trial Insights
Into the Aftermath of M&A
View Past Articles>>
Paragraph IV Patent Certifications
Emergency Use of Tamiflu in Infants Less than 1 Year of Age
Safe Use Initiative
Current Drug Shortages
Status of OTC Rulemakings

Rethinking Globalization
Find Us on Facebook
The Divide Between Patients and Trials

More Blog Posts

MDS Central Labs Deal Moves Forward
October 27, 2009
Co-founder of investment firm set to acquire MDS Global Central Labs speaks out about his purchase.
REMs: Battling the Unknowns
October 22, 2009
Why knowing a drug's risk and preparing for a risk evaluation mitigation strategy early on will considerably benefit a drug's development.
Keys to Drug Development in Latin America
October 1, 2009
The region and its regulatory agencies try to keep up with the rapidly growing clinical trials market.
Survey Reveals Biotech Professionals' Attitude Toward New Business Models
September 30, 2009
A recent, free report, reveals biotech professionals' evaluations of potential business model alternatives for the future.
Emerging Pharmas and CROs Need Each Other
September 11, 2009
How changing times require a new approach to partnerships.
Clinical Reimbursement: Keeping Everyone Happy
October 2, 2009
A Revolution in Physician Targeting: In-source analytics-driven intelligence to go beyond decile-based targeting
September 1, 2009
New Dimensions in EDC/eClinical: TMF and Document Management
July 17, 2009
Managed Innovation, Assured Compliance
July 17, 2009
Business Analytics: Six Questions to Ask About Information and Competition
April 8, 2009
Click here